| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,263 |
2,852 |
$155K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,784 |
1,574 |
$134K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,288 |
2,102 |
$37K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
347 |
316 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
941 |
792 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
319 |
266 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
658 |
275 |
$6K |
| 99307 |
|
662 |
598 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
359 |
312 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
166 |
154 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
177 |
155 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
12 |
$966.60 |
| 80061 |
Lipid panel |
104 |
87 |
$952.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
43 |
40 |
$81.82 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28 |
27 |
$23.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$6.16 |